Compono Appoints New CEO

11th May 2022

Compono, an investee company within the Deepbridge Technology Growth EIS portfolio, has appointed Trent Innes, former Managing Director of Xero Australia and Asia, as its new CEO, effective from May 2nd 2022. 

Innes will bring extensive experience to the role after spending eight years at Xero, where he worked as a national go-to-market director for two years before being promoted in 2016. 

SmallSpark Awarded Funding By Research England

18th May 2022

SmallSpark Space Systems, an award-winning rocket propulsion innovation company which is part of the Deepbridge Technology Growth EIS fund, has been awarded funding by Research England via their SPRINT programme. This funding will be used to collaborate with Dr Fengshu Yang and the University of Leicester to develop a new iteration of rocket propellant for its S4-HIVE rocket engine. 

Zilico Showcased At 75th World Health Assembly

27th May 2022

Zilico Ltd, which is part of the Deepbridge Life Sciences EIS fund, will take centre stage at the World Health Assembly, the decision-making body of WHO (World Health Organisation). It is attended by delegations from all WHO Member States. The main functions of the World Health Assembly are to determine the policies of the Organisation, and review and approve the proposed programme budget. The Health Assembly is held annually in Geneva, Switzerland. 

IHT Uptick Shows Individuals Still Not Seeking Advice

30th May 2022

The uptick in inheritance tax receipts for the six months to October 31st, 2022 shows individuals are not seeking appropriate advice, according to Andrew Aldridge, Partner & Head of Marketing at Deepbridge Capital.

Andrew Aldridge, Partner & Head of Marketing at Deepbridge Capital commented: